Oritavancin diphosphate
SIGMA/SML1586 - ≥97% (HPLC)
Synonym: LY333328 diphosphate; (4"R)
CAS Number: 192564-14-0
Empirical Formula (Hill Notation): C86H97Cl3N10O26 · 2H3PO4
Molecular Weight: 1989.09
Linear Formula: C86H97Cl3N10O26 · 2H3PO4
Product Type: Chemical
assay | ≥97% (HPLC) |
color | white to beige |
form | powder |
InChI | 1S/C86H97Cl3N10O26.2H3O4P |
InChI key | PWTROOMOPLCZHB-BHYQHFGMSA |
Quality Level | 100 |
shipped in | wet ice |
solubility | H2O: 10 mg/mL, clear |
storage temp. | −20°C |
Biochem/physiol Actions: | Oritavancin is a lipoglycopeptide vancomycin analog with broad spectrum activity against gram-positive pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and organisms resistant to vancomycin and other antibiotics such as linezolid and daptomycin. Oritavancin has multiple mechanisms of action, including inhibition of transglycosylation, inhibition of transpeptidation, and cell membrane interaction/disruption. Oritavancin also has a long half-life, allowing for a single intravenous dose of rather than the standard vacomycin treatment of twice-daily infusions for ten days. |
Caution: | category 1 skin sensitizer |
Packaging: | 5, 25 mg in glass bottle |
Symbol | GHS07 |
Signal word | Warning |
Hazard statements | H317 |
Precautionary statements | P280 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥97% (HPLC) |
Storage Temp. | −20°C |
UNSPSC | 12352200 |